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D-serine is an endogenous coagonist at the glycine site of synaptic NMDA receptors
(NMDARs), synthesized by serine racemase (SR) through conversion of L-serine.
It is crucial for synaptic plasticity and is implicated in schizophrenia. Our previous
studies demonstrated specific loss of SR, D-serine-responsive synaptic NMDARs,
and glutamatergic synapses in cortical neurons lacking α7 nicotinic acetylcholine
receptors, which promotes glutamatergic synapse formation and maturation during
development. We thus hypothesize that D-serine and SR (D-serine/SR) are associated
with glutamatergic synaptic development. Using morphological and molecular studies
in cortical neuronal cultures, we demonstrate that D-serine/SR are associated with
PSD-95 and NMDARs in postsynaptic neurons and with glutamatergic synapse stability
during synaptic development. Endogenous D-serine and SR colocalize with PSD-95,
but not presynaptic vesicular glutamate transporter 1 (VGLUT1), in glutamatergic
synapses of cultured cortical neurons. Low-density astrocytes in cortical neuronal
cultures lack SR expression but contain enriched D-serine in large vesicle-like
structures, suggesting possible synthesis of D-serine in postsynaptic neurons and
storage in astrocytes. More interestingly, endogenous D-serine and SR colocalize with
PSD-95 in the postsynaptic terminals of glutamatergic synapses during early and late
synaptic development, implicating involvement of D-serine/SR in glutamatergic synaptic
development. Exogenous application of D-serine enhances the interactions of SR
with PSD-95 and NR1, and increases the number of VGLUT1- and PSD-95-positive
glutamatergic synapses, suggesting that exogenous D-serine enhances postsynaptic
SR/PSD-95 signaling and stabilizes glutamatergic synapses during cortical synaptic
development. This is blocked by NMDAR antagonist 2-amino-5-phosphonopentanoic
acid (AP5) and 7-chlorokynurenic acid (7-CK), a specific antagonist at the glycine site
of NMDARs, demonstrating that D-serine effects are mediated through postsynaptic
NMDARs. Conversely, exogenous application of glycine has no such effects, suggesting
D-serine, rather than glycine, modulates postsynaptic events. Taken together, our
findings demonstrate that D-serine/SR are associated with PSD-95 and NMDARs
in postsynaptic neurons and with glutamatergic synapse stability during synaptic
development, implicating D-serine/SR as regulators of cortical synaptic and circuit
development.
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INTRODUCTION
NMDARs are glutamate-gated ionotropic channels that
are crucial for many physiological processes including
neurotransmission, synaptic plasticity, and learning and
memory (Waxman and Lynch, 2005; Hardingham and Bading,
2010; Vyklicky et al., 2014). In addition to glutamate, NMDAR
activation requires the binding of coagonist, D-serine or glycine,
to the glycine site of NR1 subunit of NMDARs (Johnson and
Ascher, 1987; Kleckner and Dingledine, 1988; Mothet et al.,
2000, 2015; Labrie et al., 2008; DeVito et al., 2011; Papouin
et al., 2012; Li and Wang, 2013; Rosenberg et al., 2013). In some
paradigms, D-serine preferentially gates synaptic NMDARs and
glycine preferentially gates extrasynaptic NMDARs (Papouin
et al., 2012). D-serine is synthesized by serine racemase (SR)
through conversion of L-serine and degraded by D-amino acid
oxidase (DAAO) in various brain regions (Martineau et al.,
2006; Wolosker, 2006, 2011; Labrie et al., 2009; Billard, 2012;
Campanini et al., 2013; Van Horn et al., 2013). D-serine is now
recognized as an important physiological modulator in many
NMDAR-dependent processes and functions, including brain
development, synaptic transmission and plasticity, learning and
memory, and social interactions (Mothet et al., 2000, 2015; Yang
et al., 2003; Kim et al., 2005a; Labrie et al., 2008; DeVito et al.,
2011; Papouin et al., 2012; Li and Wang, 2013; Rosenberg et al.,
2013).
Abnormal reduction of D-serine levels have been found
in schizophrenia patients (Hashimoto et al., 2003, 2005;
Yamada et al., 2005; Bendikov et al., 2007) and implicated
in the pathogenesis of schizophrenia (Labrie et al., 2012).
Targeted deletion or pathogenic perturbation of SR in mice
reduces D-serine production and glutamatergic transmission in
the forebrain and leads to schizophrenia-like behavior (Basu
et al., 2009; Ma et al., 2013). SR null mutant mice, which
have less than 10% of normal brain D-serine, have reduced
dendritic spine density that can be partially rescued by chronic
D-serine treatment (Balu and Coyle, 2012; Balu et al., 2012,
2014). Disruption of D-serine/SR has also been associated
with schizophrenia during development. Neonatal disruption
of SR and D-serine synthesis in mice leads to schizophrenia-
like behavioral abnormalities in adulthood (Hagiwara et al.,
2013). Previous studies have demonstrated that glutamatergic
synapse formation and maturation are promoted by α7
nicotinic acetylcholine receptor during synaptic development
(Lin et al., 2010; Lozada et al., 2012). Glutamatergic synapses
and D-serine/SR are decreased in the forebrain of α7 nicotinic
acetylcholine receptor knockout mice (Lin et al., 2014b).
These changes resemble the major neurochemical deficits
in schizophrenia (Lin et al., 2014a,b). We thus hypothesize
that D-serine/SR may be involved in glutamatergic synaptic
development, and that D-serine/SR deficiency may thereby
disrupt cortical synaptic and circuit development, contributing
to permanent deficits in schizophrenia.
The roles of D-serine/SR in neurons and astrocytes have
been controversial. D-serine was characterized solely as a
gliotransmitter in the initial studies showing D-serine and SR
localized to astrocytes (Schell et al., 1997; Wolosker et al., 1999;
Martineau et al., 2006; Panatier et al., 2006). Using more specific
SR antibodies and SR-knockout mice as negative controls, SR
is found preferentially expressed in excitatory and inhibitory
neurons, and D-serine is predominantly produced and released
by neurons in rodent and human brains (Kartvelishvily et al.,
2006; Miya et al., 2008; Wolosker et al., 2008; Benneyworth et al.,
2012; Ehmsen et al., 2013; Balu et al., 2014; Martineau et al., 2014;
Mothet et al., 2015). SR interacts with DISC1 in astrocytes and
pathogenic disruption of SR-DISC1 binding leads to depletion
of D-serine levels and schizophrenia-like behavior in mice (Ma
et al., 2013). SR interactions with stargazin and PSD-95 have
been suggested to regulate NMDAR-AMPAR cross-talking in
neurons (Ma et al., 2014), however the association of D-serine/SR
with PSD-95 in postsynaptic neurons and their association with
synapse stability remain unknown. In the current studies, we
examined the expression and distribution of SR and D-serine
and their association with glutamatergic synapses in primary
cortical neuronal cultures containing low-density astrocytes
from embryonic mice. Our findings reveal the association
of D-serine/SR with PSD-95 and NMDARs in postsynaptic
neurons and with glutamatergic synapse stability during cortical
synaptic development based on themorphological andmolecular
evidence.
MATERIALS AND METHODS
Materials
Timed-pregnant C57BL/6 mice were purchased from Charles
River Laboratories. Biochemicals included 2-amino-5-
phosphonopentanoic acid (AP5), D-serine, L-serine, glycine
and lithium (Sigma), 7-chlorokynurenic acid (7-CK) (Tocris
Bioscience). Antibodies included α-NR1 (BD Pharmagen,
mouse monoclonal, Millipore, mouse monoclonal), α-NR2A,
α-NR2B (Alomone Labs, rabbit polyclonal), α-PSD-95 (BD
Transduction Laboratories, mouse monoclonal; NeuroMab,
mouse monoclonal), α-VGLUT1 (Synaptic Systems, polyclonal;
mouse monoclonal), α-GAD65 (DSHB, mouse monoclonal),
α-gephyrin (Synaptic systems, mouse monoclonal), α-D-serine,
α-L-serine, α-Serine Racemase (Abcam, rabbit polyclonal), α-
GFAP (Sigma, rabbit polyclonal; NeuroMab,mousemonoclonal),
α-GLT1 (obtained from Dr. Michael B. Robinson, a courtesy
of Dr. Jeffrey Rothstein, mouse monoclonal; NeuroMab, rabbit
polyclonal), α-MAP2 (Abcam, chicken polyclonal), α-GABA
(Sigma, rabbit polyclonal), α-VAMP2 (Synaptic systems, mouse
monoclonal).
Neuronal Cultures and Drug Treatment
Primary cortical cultures from E17-19 C57BL/6 mice were
prepared as described (Lin et al., 2010) in accordance with the
protocol approved by The Children’s Hospital of Philadelphia
Institutional Animal Care and Use Committee (IACUC). Briefly,
the cortex was dissected, gently minced, trypsinized (0.027%,
37◦C; 7% CO2 for 20 min), and then washed with 1 × HBSS.
Neurons were seeded to a density of 3 × 105 viable cells in
35-mm culture dish with five 12-mm glass coverslips (low-
density culture, 3× 104/cm2) or a density of 1.6× 106 viable cells
in 60-mm culture dishes (high-density culture, 8 × 104/cm2).
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The culture dishes were coated with poly-D-Lysine (100 µg/ml)
prior to seeding neurons. Neurons were maintained at 37◦C
with 5% CO2 in Neurobasal medium with B27 supplement.
Cortical cultures contain 5–10% of glia cells and 90–95% cortical
neurons. At 17–19 (high-density cultures, 8 × 104/cm2) or 23–
25 (low-density cultures, 3 × 104/cm2) days in vitro (DIV),
cultures were subject to drug treatment for 24 h, western blotting
analysis, co-immunoprecipitation and immunocytochemistry.
For drug treatment, the cortical cultures were treated with
vehicle, D-serine (50 µM), D-serine (50 µM) + AP5 (50 µM),
D-serine (50 µM) + 7-CK (50 µM), glycine (50 µM) + lithium
(100 µM) for 24 h.
For cell lysate preparation, cultures were lysed in lysis buffer
(150 mM NaCl, 1 mM EDTA, 100 mM Tris-HCl, 1% Triton X-
100, 1% sodium deoxycholate and 1% SDS, pH 7.4, supplemented
the day of use with 1:500 EDTA-free protease inhibitor cocktail
III (Calbiochem) for 1 h at 4◦C and collected. Debris was cleared
by centrifugation at 16,100 × g for 20 min at 4◦C. Supernatants
were stored at−80◦C until use.
Co-immunoprecipitation and Western
Blotting Analysis
Co-immunoprecipitation and Western blotting was performed
as described previously (Zhai et al., 2005). Protein content
of cortical lysates was determined using BCA Protein Assay
(Thermo Scientific). Equal amounts of total protein lysates
(250 µg) were first added 2 µg primary antibody (α-SR, α-
NR1, or α-PSD-95) or normal IgG and incubated at 4◦C for
2h. Immunocomplexes were then precipitated with protein
A or protein G-agarose beads shaking overnight at 4◦C,
washed twice in lysis buffer, eluted by boiling in SDS-PAGE
sample buffer, and subjected to Western blot analysis. Equal
volumes of eluted buffers for co-immunoprecipitation assay
or equal amounts of total protein (15 µg cell lysate) for
protein input analysis were subjected to 4–12% NuPAGE Gel
for electrophoresis and transferred to nitrocellulose membranes.
Membranes were blocked with 3% nonfat milk and incubated
with primary antibody overnight at 4◦C. Blots were then
incubated with appropriate horseradish peroxidase, HRP-
conjugated secondary antibodies (Cell Signaling) for 2 h at
room temperature and then washed; Reaction bands were
visualized using a luminol-enhanced chemiluminescence (ECL)
HPR substrate (Thermo Scientific). Each blot was then
incubated with stripping buffer (2% SDS, 50mM Tris, pH
6.8, and 100mM β-mercaptoethanol) for 45 min at room
temperature to remove the signals and reprobed for other
proteins. For quantification analysis, reaction product levels
were quantified by scanning densitometry and the ratio of
co-precipitated protein was normalized by input levels from
3 different cultures and experiments using NIH Image J
software.
Immunocytochemistry and Fluorescence
Imaging
Primary cultured cortical neurons were fixed for 20 min at 4◦C
with 4% paraformaldehyde in phosphate-buffered saline (PBS)
(pH 7.4), and then subjected to the immunostaining procedure.
For immunostaining procedure, after blocking with 5% normal
goat serum and 1% bovine serum albumin in combination
with 0.3% (vol/vol) Triton X-100 in PBS at room temperature
for 1 h, the coverslips or slides were incubated with primary
antibodies at 4◦C overnight and then secondary antibodies
conjugated to Alexa fluor 488 or 568 or 647 (Invitrogen) at
room temperature for 60–90 min. Following several washes
with PBS, cells or slides were mounted with Vectashield
with DAPI (Vector Laboratories). Fluorescence images were
obtained with Olympus FluoView and Leica TCS SP8 laser
scanning confocal microscope. For quantification analysis of
glutamatergic synapses in cortical cultures, neurons were stained
for glutamatergic synaptic markers (VGLUT1 and PSD-95).
The confocal images were acquired under 40x objectives with
zoom x6 from the dendrites of 5 neurons and 3 different
cultures for quantification of VGLUT1-positive puncta on the
dendrites of cortical neurons. NIH Image J software and the
thresholded images were used to quantify the number of
glutamatergic synapses on the primary and secondary dendrites
of cortical neurons. Since nearly 100% of VGLUT1-positive
puncta were colocalized with or adjacent to one or more PSD-
95-positive puncta in the dendrites of cortical neurons, the
number of VGLUT1-positive puncta reasonably represents the
number of glutamatergic synapses on the dendrites (Lin et al.,
2014b).
Statistical Analysis
Data was shown as the mean ± S.E.M. Experiments were
analyzed using Student’s t-test to compare two conditions
or ANOVA followed by planned comparisons of multiple
conditions. Significance was set at P < 0.05.
RESULTS
Serine Racemase (SR) Colocalizes with
PSD-95, But Not Presynaptic VGLUT1, in
Glutamatergic Synapses of Cortical
Glutamatergic and Gabaergic Neurons
SR is an endogenous biosynthetic enzyme that converts L-seine
to D-serine, and DAAO is an endogenous D-amino acid oxidase
that degrades D-serine in the nervous system. To explore the
possible role of D-serine in cortical synaptic development,
we first examined the expression and distribution of SR and
DAAO in primary cortical neuronal cultures at 28 days in vitro
(DIV) by immunocytochemical studies using antibodies to SR,
DAAO, astrocytic marker (glutamate transporter 1, GLT1) and
neuronal markers (Microtubule-associated protein 2, MAP2).
Immunostaining with astrocytic and neuronal marker antibodies
indicates that cortical neuronal cultures contain 5–10% glial
cells and 90–95% cortical neurons. Triple immunostaining
with α-SR or α-DAAO and α-MAP2 and α-GLT1 show
that SR is abundantly distributed in the soma, nucleus and
dendrites of MAP2-positive cortical neurons (N) (Figure 1A),
but absent in the soma and astrocytic terminals of GLT1-
positive astrocytes (AS) (Figure 1B) in cortical neuronal cultures
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FIGURE 1 | SR is abundant in cortical neurons but absent in low-density astrocytes in primary cortical neuronal cultures. (A–F) Confocal images of SR or
DAAO immunofluorescence (red), GLT1 immunofluorescence (green), MAP2 immunofluorescence (cyan) and DAPI staining (blue) in primary cortical neuronal cultures
with low-density astrocytes showing that SR appears abundantly in the MAP2-positive cortical neurons (N) (A) but absent in GLT1-positive astrocytes (AS) (B).
D-serine degrading enzyme DAAO is abundantly present in the GLT1-positive astrocytes (AS) (E) but absent in MAP2-positive cortical neurons (N) (D). (G–L) Higher
magnification of confocal images showing that SR appears abundant in the synaptic-like structures on MAP2-positive dendrites of cortical neurons (N), but absent in
GLT1-positive astrocytes (AS). Scale bars as indicated.
(Figure 1C). In contrast, DAAO is abundantly distributed
in the soma of GLT1-positive astrocytes (AS) (Figure 1E),
but absent in MAP2-positive neurons (N) (Figure 1D) in
cultures (Figure 1F), suggesting possible synthesis of D-serine
in neurons and degradation in astrocytes. High magnification
confocal images further show that the majority of SR appears
as puncta in the synaptic-like structures (Figures 1H,K)
on the MAP2-positive dendrites (Figures 1G,J). Noticeably,
some SR-positive puncta on the MAP2-positive dendrites are
close to or overlap with GLT1-positive astrocytic membranes
(Figures 1I–L).
To define the nature of SR distribution in the synaptic-like
structures on the dendrites, we examined whether SR is located
in glutamatergic or GABAergic synapses using antibodies to
glutamatergic and GABAergic presynaptic and postsynaptic
markers. We first characterized cortical glutamatergic and
GABAergic neurons in cultures using the GABAergic
neuronal marker GABA as well as glutamatergic markers
PSD-95 and VGLUT1. In GABA-positive cortical GABAergic
interneurons, GABA is distributed in the soma, dendrites
as well as axonal and presynaptic terminals surrounding
glutamatergic neurons (Supplemental Figures 1A–C), and
PSD-95 is localized in the shaft-like synapses on the somatic
and dendritic membrane (Supplemental Figures 1A–F). In
cortical glutamatergic neurons surrounded by GABA-positive
synaptic terminals, PSD-95 is distributed in the soma and
in the spine-like synapses on the dendrites (Supplemental
Figures 1G–I). Co-immunostaining with PSD-95 and VGLUT1
antibodies further confirms PSD-95- and VGLUT1-positive
shaft-like synapses on cortical GABAergic interneurons
(Supplemental Figures 1J–L) as well as dendritic spine-like
synapses on cortical glutamatergic neurons (Supplemental
Figures 1M–O).
Based on co-immunostaining with antibodies to
glutamatergic presynaptic and postsynaptic markers (VGLUT1
and PSD-95), SR colocalizes with PSD-95-positive glutamatergic
postsynaptic terminals on the dendrites of cortical glutamatergic
(Figures 2A–F) and GABAergic neurons (Figures 2G–L),
but does not colocalize with VGLUT1-positive glutamatergic
presynaptic terminals on the dendrites of cortical glutamatergic
(Figures 3A–F) and GABAergic neurons (Figures 3G–L). In
addition, co-immunostaining with antibodies to GABAergic
presynaptic and postsynaptic markers (GAD65 and gephyrin)
shows that SR does not colocalize with GAD65-positve
GABAergic presynaptic (Supplemental Figures 2A–F)
or gephyrin-positive GABAergic postsynaptic terminals
(Supplemental Figures 2G–L) on cortical glutamatergic
neurons (Supplemental Figures 2A–C,G–I) and GABAergic
neurons (Supplemental Figures 2D–F,J–L). Taken together,
these results indicate that SR is a postsynaptic protein that
colocalizes with PSD-95 in glutamatergic synapses of cortical
neurons.
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FIGURE 2 | SR is a postsynaptic protein that colocalizes with PSD-95 in the glutamatergic synapses on cortical glutamatergic and GABAergic
neurons. Confocal images of SR immunofluorescence (red) and PSD-95 immunofluorescence (green) showing that SR appears as puncta in the soma, nucleus and
dendrites of cortical neurons (A,D,G,J) in primary cortical neuronal cultures at 28 DIV. SR colocalizes with PSD-95-positive glutamatergic postsynaptic terminals
(B,E,H,K) on the dendrites of cortical glutamatergic (C,F) and GABAergic (I,L) neurons as characterized by PSD-95 immunofluorescence shown in Supplemental
Figure 1. Scale bars as indicated.
Endogenous D-Serine Colocalizes with
PSD-95-Positive Glutamatergic
Postsynaptic Terminals on Cortical
Glutamatergic and Gabaergic Neurons
The distribution of D-serine was directly examined in cortical
cultures using triple immunostaining with α-D-serine antibody
along with antibodies to neuronal (α-MAP2) and astrocytic
markers (α-GFAP). To determine the specificity of α-D-
serine antibody, we first compared the immunoreactivities
of α-D-serine and α-L-serine antibodies, D-serine appears
abundant as puncta in the soma and dendrites of MAP2-
positive cortical neurons and in the soma of astrocytes
(Supplemental Figures 3A–D), whereas L-serine is diffusely
distributed in GFAP-positive astrocytes and very low in
cortical neurons (Supplemental Figures 3E–H), suggesting the
specificity of D-serine immunoreactivity and matching the
findings on astrocytic supply of L-serine (Ehmsen et al.,
2013). Furthermore, D-serine is abundant in the soma
and in the synaptic-like structures on the MAP2-positive
(Figures 4A,D,G) dendrites of cortical neurons (N) in
cortical cultures (Figures 4C,F,I), whereas D-serine appears
enriched as large puncta in the soma of GFAP-positive
(Figures 4B,E,H) astrocytes (AS). Co-immunostaining with
synaptic vesicle membrane associated protein 2 (VAMP2)
antibody shows that D-serine appears enriched in large
vesicle-like structures (1–3 µm) which are VAMP2-negative in
the soma of astrocytes (AS) (Figures 4J–L), and that D-serine
is abundant in the dendrites but absent in the VAMP2-positve
presynaptic terminals on the dendrites of cortical neurons
(Figures 4J,L).
We further defined the localization of D-serine within
glutamatergic presynaptic and postsynaptic terminals of
cortical neurons. Co-immunostaining with α-D-serine and
α-PSD-95 antibodies shows that D-serine appears in the
synaptic-like structures that colocalize with PSD-95 on the
dendrites of cortical glutamatergic (Figures 5A–C) and
GABAergic neurons (Figures 5G–I). High magnification of
confocal images confirms that D-serine colocalizes with PSD-
95-positive postsynaptic terminals in the spine-like synapses
on cortical glutamatergic neurons (Figures 5D–F) and in
the shaft-like synapses on cortical GABAergic interneurons
(Figures 5J–L), suggesting the localization of D-serine in
postsynaptic neurons. Moreover, co-immunostaining with
antibodies to D-serine and the glutamatergic presynaptic
terminal marker α-VGLUT1 shows that D-serine is adjacent
to, but does not colocalize with, VGLUT-positive glutamatergic
presynaptic terminals on cortical glutamatergic (Figures 6A–F)
and GABAergic neurons (Figures 6G–L). Taken together,
our findings demonstrate D-serine association with PSD-95
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FIGURE 3 | SR is absent in glutamatergic presynaptic terminals on cortical glutamatergic and GABAergic neurons. Confocal images of SR
immunofluorescence (red) and VGLUT1 immunofluorescence (green) showing that SR appears as puncta in the soma, nucleus and dendrites of cortical neurons
(A,D,G,J). SR does not colocalize with VGLUT1-positive glutamatergic presynaptic terminals (B,E,H,K) on cortical glutamatergic (C,F) and GABAergic (I,L) neurons
as characterized by VGLUT1 and PSD-95 immunofluorescence shown in Supplemental Figure 1. Scale bars as indicated.
in postsynaptic neurons and possible storage of D-serine in
astrocytes.
Endogenous SR and D-Serine Colocalize
with PSD-95 in the Postsynaptic Terminals
of Glutamatergic Synapses of Cortical
Neurons during Early Synaptic
Development
Previous findings suggest that D-serine/SR may be involved
in glutamatergic synaptic development (Balu et al., 2013,
2014; Ma et al., 2013; Lin et al., 2014b). To test this, we
further examined the association of D-serine/SR with PSD-
95 in early cortical cultures (16 DIV and 23 DIV). Co-
immunostaining with α-SR and α-PSD-95 antibodies shows
that, in cortical neuronal cultures at 16 DIV, SR (Figure 7A)
is located in the postsynaptic terminals of spine-like synapses
and colocalizes with PSD-95 (Figure 7B) on the MAP2-positive
dendrites (Figure 7C) of cortical neurons. At 23 DIV, the
number of glutamatergic synapses increases on the MAP2-
positive dendrites of cortical neurons, and SR colocalizes
with PSD-95 in the postsynaptic terminals of glutamatergic
synapses (Figures 7D–F). Co-immunostaining with α-D-serine
and α-PSD-95 antibodies shows similar co-localization of
D-serine (Figures 7G,J) and PSD-95 (Figures 7H,K) in the
postsynaptic terminals of glutamatergic synapses (Figures 7I,L)
in early cortical cultures at 16 DIV and 23 DIV, suggesting
that D-serine/SR may be involved in PSD-95 signaling and
glutamatergic synaptic development.
Exogenous D-Serine, But Not Glycine,
Enhances the In vivo Interactions of SR
with PSD-95 and NMDARs Postsynaptically
To explore the possible involvement of D-serine/SR in
postsynaptic PSD-95 signaling, we examined the effects of
exogenous D-serine application on PSD-95 interactions with
SR and NMDARs in cortical cultures. We first confirmed
the in vivo interactions of endogenous SR with PSD-95 in
cortical neurons using co-immunoprecipitation. In cortical
neuronal lysates, α-SR antibody co-precipitates PSD-95 as well
as NR1 (Figure 8A). Similarly, α-NR1 antibody co-precipitates
SR and PSD-95 in cortical neuronal lysates (Figure 8B),
and incubation of cortical neuronal lysates with α-PSD-95
antibody co-precipitates NR1 and SR (Figure 8C). Furthermore,
α-SR antibody co-precipitates NR2A and a lesser amount
of NR2B in cortical neuronal lysates (Figure 8D). These
findings are not observed with control IgG in these assays
(Figures 8A–D). This identifies the in vivo interactions of
SR with PSD-95, NR1 and NR2 in a postsynaptic protein
complex.
To explore the possible role of D-serine in postsynaptic
functions, we examined the effects of exogenous application
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FIGURE 4 | D-serine is abundant in cortical neurons and enriched in low-density astrocytes in primary cortical neuronal cultures. (A–I) Confocal images
of D-serine immunofluorescence (red), GFAP immunofluorescence (green), MAP2 immunofluorescence (cyan), and DAPI nucleus staining (blue) showing that D-serine
appears abundantly in the soma and dendrites of MAP2-positive cortical neurons (N) (A) and in the soma of GFAP-positive astrocytes (AS) (B). Higher magnification of
confocal images (D–I) showing that D-serine appears abundant in the synaptic-like structures on MAP2-positive dendrites (D,G) and enriched in large vesicle-like
structures (1–3 µm) in the soma of GFAP-positive astrocytes (E,H). (J–L) Confocal images of D-serine immunofluorescence (red), VAMP2 immunofluorescence
(green), and DAPI staining (blue) showing that D-serine appears abundant in the soma and dendrites of cortical neurons surrounded by VAMP2-positive presynaptic
terminals (N) and enriched in the soma of VMAP2-negative astrocytes (AS) (J). Higher magnification of confocal image confirms that D-serine appears in large
vesicle-like structures (1–3 µm) in the soma of VMAP2-negative astrocytes (AS) (K) and in the dendrites of cortical neurons surrounded by VAMP2-positive
presynaptic terminals (L). Scale bars as indicated.
of D-serine on the in vivo interactions of SR with PSD-95
and NMDARs using co-immunoprecipitation assays with α-SR
antibody. Exogenous application of D-serine markedly increases
the amount of PSD-95 and NR1 co-immunoprecipitated by
α-SR antibody from the same amount of cortical neuronal
lysate, even though the levels of PSD-95, NR1 and SR
inputs remain similar between the control and treatment
groups (Figures 9A–C). The ratios of co-precipitated NR1
and PSD-95 normalized to input controls are significantly
increased in D-serine-treated cortical lysates (Figures 9D–F).
The results suggest that exogenous D-serine enhances the
in vivo interactions of SR with NR1 and PSD-95. This
enhancement is blocked by co-application of AP5, an NMDAR
competitive antagonist, as well as with 7-chlorokynurenic acid
(7-CK), a specific NMDAR competitive antagonist at the
glycine site of NMDARs (Figures 9A–F), demonstrating that
D-serine modulates SR/PSD-95 interactions through NMDAR
activation. In contrast, exogenous application of glycine along
with glycine transporter inhibitor lithium, does not have the same
effect on SR interactions with NR1 and PSD-95 as exogenous
D-serine (Figures 9A–F), suggesting that D-serine, rather than
glycine, modulates postsynaptic SR interactions with PSD-95 and
NMDARs.
Exogenous D-Serine, But Not Glycine,
Stabilizes Cortical Glutamatergic Synapses
We then examined the effects of exogenous D-serine on
glutamatergic synapses in cortical cultures (23-25DIV) by
immunocytochemical studies with antibodies to glutamatergic
synaptic markers (α-VGLUT1 and α-PSD-95). Exogenous
application of D-serine for 24 h dramatically increases the
number of VGLUT1- and PSD-95-positive synapses in cortical
cultures (Figures 10D–F) compared with control cultures
(Figures 10A–C) with a more pronounced effect on presynaptic
terminals. This suggests that D-serine may increase the number
of glutamatergic synapses through synapse stabilization. The
increase in synapse number is blocked by the NMDAR antagonist
7-CK (Figures 10G–I), whereas exogenous application of glycine
along with the glycine transporter inhibitor lithium does not
increase the number of glutamatergic synapses (Figures 10J–L).
Higher magnification of confocal images further show that
D-serine, but not glycine, increases the number of VGLUT-1-
and PSD-95-positive glutamatergic synapses on the dendrites
of cortical neurons, which can be blocked by the NMDAR
antagonist 7-CK (Figures 10A’–L’). Quantification confirms that
D-serine, but not glycine, significantly increases the number
of glutamatergic synapses on the dendrites, and that this
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FIGURE 5 | D-serine colocalizes with PSD-95-positive postsynaptic terminals on cortical glutamatergic and GABAergic neurons. (A–F) Confocal images
of D-serine immunofluorescence (red), PSD-95 immunofluorescence (green), and DAPI nucleus staining (blue) showing that D-serine (A,D) colocalizes with PSD-95
(B,E) in the spine-like synapses on the dendrites of cortical glutamatergic neurons in primary cortical neuronal cultures at 28 DIV (C,F). (G–L) Confocal images
showing that D-serine (G,J) colocalizes with PSD-95 (H,K) in the shaft-like synapses on the dendrites of cortical GABAergic neurons (I,L) as characterized by PSD-95
immunofluorescence shown in Supplemental Figure 1. Scale bars as indicated.
increase can be blocked by 7-CK (Figure 10M). The findings
thus demonstrate that D-serine, unlike glycine, stabilizes
glutamatergic synapses on the dendrites of cortical neurons
through NMDARs.
DISCUSSION
The present study uses in vitro cultured cortical neurons to show
that D-serine and SR are associated with PSD-95 and NMDARs
in postsynaptic neurons and with glutamatergic synapse stability.
Endogenous D-serine and SR colocalize with PSD-95, but not
presynaptic VGLUT1, and is highly enriched in the postsynaptic
density of glutamatergic synapses of cortical neurons. Low-
density astrocytes in cortical cultures lack SR expression
but contain enriched D-serine in large vesicle-like structures,
suggesting possible synthesis of D-serine in postsynaptic neurons
and separate storage of D-serine in astrocytes. More interestingly,
endogenous D-serine and SR colocalize with PSD-95 in
the postsynaptic terminals of glutamatergic synapses during
early and late synaptic development, implicating D-serine/SR
involvement in glutamatergic synaptic development. Exogenous
application of D-serine enhances SR interactions with PSD-
95 and NMDARs in a postsynaptic protein complex and
increases the number of glutamatergic synapses, suggesting
that exogenous D-serine enhances postsynaptic SR/PSD-95
signaling and stabilizes glutamatergic synapses during synaptic
development. This is blocked by the NMDAR antagonists
AP5 and 7-CK, a specific antagonist at the glycine site
of NMDARs. In contrast, exogenous application of glycine
has no such effects, suggesting that the D-serine effects are
mediated through synaptic NMDARs. The present results thus
implicate D-serine and SR in control of PSD-95 signaling and
glutamatergic synapse stability during cortical synaptic and
circuit development.
The localization of SR and D-serine in astrocytes and
neurons remains disputed. SR was initially localized to
astrocytes, but later found prominently in neurons (Schell
et al., 1997; Wolosker et al., 1999, 2008; Kartvelishvily et al.,
2006; Martineau et al., 2006, 2014; Panatier et al., 2006;
Miya et al., 2008; Benneyworth et al., 2012; Ehmsen et al.,
2013; Balu et al., 2014; Mothet et al., 2015). Our results
show that SR is a postsynaptic protein that colocalizes
with PSD-95, a glutamatergic postsynaptic terminal marker,
but not presynaptic marker VGLUT1, in the glutamatergic
synapses of cortical glutamatergic and GABAergic neurons. Co-
immunoprecipitation confirms endogenous SR interactions with
PSD-95 and NMDARs postsynaptically and co-immunostaining
shows that D-serine appears enriched in PSD-95-positive
glutamatergic postsynaptic terminals on cortical neurons,
suggesting D-serine may be synthesized and produced in
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FIGURE 6 | D-serine is absent in glutamatergic presynaptic terminals on cortical glutamatergic and GABAergic neurons. Confocal images of D-serine
(B,E,H,K) red immunofluorescence (red) and VGLUT1 (A,D,G,J) immunofluorescence (green) showing that D-serine does not colocalize with VGLUT1-positive
glutamatergic presynaptic terminals on cortical glutamatergic (C,F) and GABAergic (I,L) neurons as characterized by VGLUT1 and PSD-95 immunofluorescence
shown in Supplemental Figure 1. Scale bars as indicated.
the postsynaptic terminals. Low-density astrocytes in primary
cortical neuronal cultures lack endogenous SR expression but
contain enriched D-serine in large vesicle-like structures (1–3
µm), suggesting possible storage of D-serine in astrocytes. This
matches the findings from other labs that D-serine is localized
in astrocytic synaptic-like vesicles and released as large vesicles
(1–3 µm) in astrocytes (Kang et al., 2013; Martineau et al.,
2013). The presence of the D-serine degrading enzyme DAAO
in astrocytes further suggests possible degradation of D-serine
in astrocytes. Our findings thus implicate both neuronal and
astrocytic D-serine in synaptic development and postsynaptic
functions.
Interactions between SR and PSD-95 are involved in coupling
synaptic NMDAR and AMPAR activities and functions (Ma
et al., 2014). We found that exogenous D-serine application
modulates postsynaptic SR/PSD-95/NMDAR interactions in
cortical neurons, implicating D-serine in SR/PSD-95 signaling
and postsynaptic functions. SR is a highly regulated enzyme that
interacts with several NMDAR- and AMPA receptor (AMPAR)-
interacting proteins including GRIP1, PICK1, DISC1, stargazin,
and PSD-95 (Kim et al., 2005b; Fujii et al., 2006; Hikida et al.,
2008; Ma et al., 2013, 2014). The physiological interactions
of SR with these receptor-interacting proteins may affect SR
translocation to the plasma membrane and SR catalytic activity
as well as synaptic NMDAR-AMPAR activities. For instance,
NMDAR activation promotes translocation of SR to the plasma
membrane, which dramatically reduces the enzyme activity
(Balan et al., 2009). AMPAR activation dissociates SR from
the protein complex on the membranes and translocates it
to the cytosol leading to enhanced activity of SR to generate
more D-serine (Ma et al., 2014). SR interactions with DISC1,
PICK1, and GRIP1 also modulate SR activity and D-serine
production (Kim et al., 2005b; Ma et al., 2014; Nomura
et al., 2016). Our findings suggest that D-serine may control
postsynaptic SR activity and D-serine production through
modulation of SR interactions with PSD-95, NMDAR and other
postsynaptic scaffold proteins. Furthermore, PSD-95 is a crucial
postsynaptic scaffold protein that regulates glutamatergic synapse
formation and maturation (Migaud et al., 1998; El-Husseini
et al., 2000; Nikonenko et al., 2008). For example, PSD-95
promotes spine synapse formation through direct interaction
with postsynaptic neuronal nitric oxide synthase (nNOS) and
drives presynaptic and postsynaptic maturation of glutamatergic
synapses (El-Husseini et al., 2000; Nikonenko et al., 2008).
PSD-95 also controls synaptic AMPAR number through direct
interaction with stargazin (Schnell et al., 2002). Therefore, our
findings suggest that D-serine could modulate postsynaptic PSD-
95 signaling, possibly through interactions with nNOS and
synaptic AMPARs, thereby modulating glutamatergic synaptic
development.
Our findings further reveal that endogenous D-serine
and SR colocalize with PSD-95 in the postsynaptic terminals
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FIGURE 7 | Endogenous SR and D-serine colocalize with PSD-95 in the postsynaptic terminals of glutamatergic synapses during early synaptic
development. (A–F) Confocal images of SR immunofluorescence (red), PSD-95 immunofluorescence (green), and MAP2 immunofluorescence (cyan) showing
colocalization of SR (A,D) with PSD-95 (B,E) in the spine-like synapses on the MAP2-positive dendrites (C,F) of cortical neurons at 16DIV (A–C) and 23 DIV (D–F).
(G–L) Confocal images of D-serine immunofluorescence (red) and PSD-95 immunofluorescence (green) showing colocalization of D-serine (G,J) with PSD-95 (H,K) in
the spine-like synapses on the dendrites (I,L) of cortical neurons at 16DIV (G–I) and 23 DIV (J–L). Scale bars as indicated.
FIGURE 8 | In vivo interactions of endogenous SR with PSD-95 and NMDARs postsynaptically in cortical neurons. (A) In normal cortical neurons,
co-immunoprecipitation (IP) of endogenous PSD-95 and NR1 with SR antibody in cortical neuronal lysates was observed, but co-precipitation with normal IgG was
not; (B), Co-IP of endogenous PSD-95 and SR with NR1 antibody in cortical neuronal lysates was observed, but co-precipitation with normal IgG was not; (C). Co-IP
of NR1 and SR with PSD-95 antibody was observed, but co-precipitation with normal IgG was not; (D). Co-IP of NR2A and a lesser amount of NR2B with SR
antibody in cortical neuronal lysates was observed, but co-precipitation with normal IgG was not.
of glutamatergic synapses during early and late synaptic
development. Exogenous D-serine indeed increases the number
of VGLUT1- and PSD95-positive glutamatergic synapses
on the dendrites of cortical neurons, implicating D-serine
in control of glutamatergic synapse stability during cortical
synaptic and circuit development. Our findings also show
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FIGURE 9 | Exogenous D-serine, but not glycine, enhances the in vivo interactions of endogenous SR with PSD-95 and NMDARs postsynaptically.
(A–C) Co-immunoprecipitation of endogenous NR1 and PSD-95 with SR antibody in cortical neuronal lysates from cultures treated with vehicle, D-serine (50 µM),
D-serine (50 µM) + AP5 (50 µM), D-serine (50 µM) + 7-CK (50 µM), glycine (50 µM) + lithium (100 µM) for 24 h. Upper panel: Co-immunoprecipitation assays of
cortical lysates (250 µg each lane); Lower panel: Western blot analysis of input levels in cortical lysates (15 µg each lane). Graphs (D–F) show quantification analysis
of the co-precipitated NR1, PSD-95, and SR with α-SR antibody in the cortical lysates from 3 different cultures and experiments. The co-precipitated products were
normalized to inputs levels in cortical lysates.
that the D-serine effects on glutamatergic synapses appears
more pronounced on presynaptic than postsynaptic terminals,
suggesting that D-serine may stabilize glutamatergic synapses
through nitric oxide retrograde signaling via postsynaptic
PSD-95/NOS interactions. SR null mutant mice, which have
less than 10% of normal brain D-serine and a schizophrenia-
like phenotype, have reduced dendritic spine density that
can be partially rescued by chronic D-serine treatment
(Balu and Coyle, 2012; Balu et al., 2012, 2014). In addition,
disruption of D-serine synthesis in mice during early postnatal
life leads to schizophrenia-like behavioral abnormalities
in adulthood, which can be rescued by chronic D-serine
treatment during juvenile life (Hagiwara et al., 2013).
Similarly, targeted deletion of the SR-interacting protein
PICK1 in mice leads to D-serine deficiency in prefrontal
cortex and schizophrenia-like behavioral abnormalities.
The abnormalities can be rescued by transient neonatal
supplementation of D-serine, but not by a similar treatment
in adulthood, implicating D-serine in brain development
(Nomura et al., 2016). Our findings suggest that D-serine/SR
may regulate cortical glutamatergic synaptic development,
which could be disrupted by abnormal D-serine/SR levels
in early life leading to permanent deficits in adulthood
in schizophrenia. Hence, D-serine treatment may provide
a potential therapeutic for rescuing synaptic deficits in
schizophrenia.
Synaptic and extrasynaptic NMDARs are associated with
differential gene expression and have different roles in synaptic
plasticity and cell death (Hardingham and Bading, 2010;
Gladding and Raymond, 2011; Kaufman et al., 2012; Papouin
et al., 2012; Karpova et al., 2013; Parsons and Raymond,
2014). D-serine preferentially gates synaptic NMDARs while
glycine preferentially gates extrasynaptic NMDARs (Papouin
et al., 2012). Our studies show that D-serine and glycine
have differential effects on postsynaptic SR/PSD-95 signaling
and glutamatergic synapse stability, implicating D-serine, rather
than glycine, in controlling postsynaptic protein signaling and
glutamatergic synaptic development. This is likely mediated
by synaptic, rather than extrasynaptic, NMDARs. Synaptic
NMDARs play crucial roles in many forms of synaptic
plasticity, such as LTP and LTD. Similarly, the selective control
of synaptic NMDARs may provide a mechanism by which
D-serine regulates glutamatergic synaptic development and
function.
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FIGURE 10 | Exogenous D-serine, but not glycine, increases the number of glutamatergic synapses in cortical cultures. Confocal images (A–L) of
α-VGLUT1 (A,D,G,J) immunofluorescence (red) and α-PSD-95 (B,E,H,K) immunofluorescence (green) shows that VGLUT1- and PSD-95-positive glutamatergic
synapses surrounding cortical neurons are markedly increased by 50 µM exogenous D-serine (D–F), but not 50 µM glycine + 100 µM lithium (J–L) compared with
control cortical neurons (A–C). This increase can be blocked by co-application of 50 µM 7-CK with 50 µM D-serine (G–I). Higher magnification of confocal images
(A’–L’) showing VGLUT1- and PSD-95-positive glutamatergic synapses on the dendrites of cortical neurons in control (A’–C’), D-serine (D’–F’), D-serine+7-CK
(G’–I’), glycine+lithium (J’–L’) groups. Graph (M) shows quantification of the number of VGLUT1-positive glutamatergic synapses on the dendrites of cortical neurons
from 3 different cultures and experiments. Scale bars as indicated.
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